BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11014092)

  • 1. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
    Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
    Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
    Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
    J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
    J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
    Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
    Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer.
    van der Ent FW; Kengen RA; van der Pol HA; Hoofwijk AG
    Eur J Surg Oncol; 1999 Feb; 25(1):24-9. PubMed ID: 10188850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
    Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
    Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
    de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
    Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
    J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study.
    Koizumi M; Nomura E; Yamada Y; Takiguchi T; Tanaka K; Yoshimoto M; Makita M; Sakamoto G; Kasumi F; Ogata E
    Nucl Med Commun; 2003 Jun; 24(6):663-70. PubMed ID: 12766602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
    Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
    J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
    Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.
    Bertoglio S; Sandrucci S; Percivale P; Goss M; Gipponi M; Moresco L; Mussa B; Mussa A
    J Surg Oncol; 2004 Mar; 85(3):166-70. PubMed ID: 14991889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
    Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
    J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma].
    Meijer S; Collet GJ; Pijpers HJ; van Hattum L; Hoekstra OS
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2239-43. PubMed ID: 8984370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.